These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3325930

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pefloxacin--a laboratory and clinical evaluation of a new quinolone. Based on papers presented at the 14th International Congress of Chemotherapy. Kyoto, Japan, June 1985.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-118. PubMed ID: 3458695
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The role of quinolones in staphylococcal infection.
    Shah PM.
    J Chemother; 1989 Aug; 1(4):253-6. PubMed ID: 2809692
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Treatment of septicemia and endocarditis with pefloxacine. 15 cases].
    Wolff M, Pangon B, Regnier B, Rouveix E, Bauchet J, Vachon F.
    Presse Med; 1986 Mar 08; 15(10):471-4. PubMed ID: 2938091
    [Abstract] [Full Text] [Related]

  • 30. Sulphenazone sensitivity of some pathogens, and its effect in diseases of the upper respiratory tract.
    Korányi G, Pesti E, Somogyi G.
    Acta Paediatr Acad Sci Hung; 1972 Mar 08; 13(3):225-30. PubMed ID: 4631517
    [No Abstract] [Full Text] [Related]

  • 31. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P, Mazzei T, Nicoletti P.
    Chemioterapia; 1987 Apr 08; 6(2):75-8. PubMed ID: 3474081
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical uses of nalidixic acid analogues: the fluoroquinolones.
    Høiby N.
    Eur J Clin Microbiol; 1986 Apr 08; 5(2):138-40. PubMed ID: 3013628
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The comparative in-vitro activity of pefloxacin.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Apr 08; 17 Suppl B():1-10. PubMed ID: 2940213
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pefloxacin: evolution of in vitro activity during 18 months of use in an intensive care unit.
    Tigaud S, Marcatello A, Gille Y, Robert D, Vincent P.
    Drugs Exp Clin Res; 1985 Apr 08; 11(3):169-76. PubMed ID: 3869804
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.